GREGORY, Walter Martin,TERCERO, Juan Carlos,COLEMAN, Robert E.,GOMIS, Roger
申请号：
AU2018372762
公开号：
AU2018372762A1
申请日:
2018.11.21
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
The present invention relates to the design of a customized therapy for a subject with breast cancer based on the c-MAF expression level and the menopausal status of the subject. In some embodiments, the customized therapy comprises an agent for avoiding, treating or preventing bone degradation. In some embodiments, the agent for avoiding, treating or preventing bone degradation is zoledronic acid. In other embodiments, the agent is clodronate or denosumab.
